Latest filing published 22 Jul 2026 for NewAmsterdam Pharma Co N.V., €260k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
All filings by Louise Frederika Kooij on record concern NewAmsterdam Pharma Co N.V. In total, 21 filings cover trades dated from 27 September 2024 to 20 July 2026.
On the market, this insider has only sold: 8 sales, €3.4M in total. No amount is published for 2 filings, which the totals therefore leave out. Outside the open market, there are 1 share grant and 12 option exercises. 2026 to date brings no purchases and 6 sales.
The record was last updated on 22 July 2026 with an open-market sale (€1.8M) in NewAmsterdam Pharma Co N.V. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
21 of 21 declarations